MedTrace Logo

Urinary Tract Infection in Patients With Chronic Kidney Disease

NCT05674942 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 250

Last updated 2024-06-18

No results posted yet for this study

Summary

This study aims to investigate the etiology and associated risk factors for UTI in Egyptian chronic kidney disease patients. In addition, to identify the isolated micro-organisms and their sensitivity patterns for better anticipation of treatment regimen.

Conditions

Interventions

OTHER

Patients with urinary tract infection and chronic kidney disease

The data that will be collected from the electronic patient records at the clinics through a google form will include sociodemographic (age, sex, weight and occupation), comorbidities (e.g., HTN, DM), medications used, renal functions (serum creatinine, and CKD stage calculated by 2021 CKD-EPI creatinine equation), and in case of positive urine culture (type of microorganism and antibiogram).

Sponsors & Collaborators

  • Alexandria University

    lead OTHER

Principal Investigators

  • mohamed mamdouh elsayed, MD · Lecturer of Nephrology & Internal Medicine, Faculty of medicine, Alexandria University

  • Mohammed Abdel Gawad · Nephrology Lecturer, School of Medicine, New Giza University (NGU), Giza, Egypt

  • Dalia Elzayat · Faculty of Pharmacy, Pharos University, Alexandria, Egypt

  • Reham Mekawy · Faculty of Pharmacy, Pharos University, Alexandria, Egypt

  • Salma Mahdy · Faculty of Pharmacy, Pharos University, Alexandria, Egypt

  • Salma Imam · Faculty of Pharmacy, Pharos University, Alexandria, Egypt

  • Hala Abo El-hassan · Faculty of Pharmacy, Pharos University, Alexandria, Egypt

  • Ramy Elwaraky · Department of Clinical Pharmacy, Kidney and Urology Center, Alexandria, Egypt

  • Engy Emam · Clinical Pharmacist, Alexandria Main University Hospital, Alexandria, Egypt

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-06-01
Primary Completion
2024-04-15
Completion
2024-05-15

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05674942 on ClinicalTrials.gov